About this trial
This study enrolls patients scheduled to undergo curative surgery for colorectal cancer. Bowel sounds will be assessed preoperatively and postoperatively. By comparing intraoperative variables, the incidence of perioperative complications, reoperation rates, and postoperative outcomes-including time to first flatus, resumption of oral intake, and occurrence of intestinal obstruction-this study aims to investigate the association between perioperative bowel sounds and postoperative recovery, and provide evidence-based support for the clinical application of bowel sound monitoring.
Supplementary Definitions
Eligibility criteria
Qualifiers
Aged 18-80 years.
Histopathologically confirmed colorectal adenocarcinoma according to the WHO 2022 classification.
No restriction on prior neoadjuvant or other antitumor therapies, including chemotherapy, radiotherapy, targeted therapy, or immunotherapy.
Able to understand the study requirements and voluntarily provide written informed consent (patient and/or legally authorized representative).
Disqualifiers
Severe cardiac dysfunction (NYHA Class III or IV).
Severe hepatic dysfunction (MELD score >12).
Severe renal dysfunction (eGFR <30 mL/min/1.73 m² [CKD stage 4-5] or end-stage renal disease requiring dialysis).
Severe pulmonary dysfunction (resting PaO₂ <60 mmHg on room air or respiratory failure requiring long-term oxygen therapy or mechanical ventilation).
Trial design
Treatments tested in this trial
- colorectal surgery
Treatment groups
Sponsors and collaborators
Zhongnan Hospital
Lead sponsor
Wuhan University
Collaborator